« March 2007 | Main | May 2007 »

Apr27
Rib-X Pharmaceuticals Collaborates with Medical Research Council

Rib-X Pharmaceuticals, Inc. and the Laboratory of Molecular Biology of the Medical Research Council (MRC) have entered into a research collaboration in the area of ribosome and antibiotic structure and function.

Under the terms of agreement, Rib-X and the MRC will jointly explore the high resolution crystal structure of the full 70S ribosome recently discovered by the MRC's world-renowned ribosome scientist, Venki Ramakrishnan, Ph.D.

rib-x_pharmaceuticals.gifThe 70S ribosome is a macromolecular machine composed of protein and RNA whose function is to convert genetic information into proteins essential for life, composed of two major components: a large (50S) and a small (30S) subunit.

According to Dr. Susan Froshauer, President and Chief Executive Officer of Rib-X:

"Rib-X is very pleased to be able to collaborate with Dr. Ramakrishnan and the MRC in this important research area. We are excited about the prospect of building on our knowledge to further our insights into how antibiotics interact at the atomic level with disease producing bacteria."
Find more details from the full report.
Apr27
Eli Lilly’s Canine Separation Anxiety Drug Reconcile™, Approved for Marketing by the USFDA
Cytos Biotech Signed License Agreement with Novartis for Nicotine Addiction Vaccine
ADVENTRX’s ANX-514 (Docetaxel Emulsion) Demonstrated Positive Data from Preclinical Pharmacokinetic Testing
Apr26
R&D Directions’ Great Investigational Drugs of 2007 Included Avicena's Huntington's Disease Drug Candidate
Astex’s Cytochrome P450, Licensed to GlaxoSmithKline
U.S. Marketing Rights to ALZA Corp.’s OROS® Hydromorphone, Bagged by Neuromed Pharmaceuticals
USFDA Gave Go Signal to Exelixis’ Clinical Trial of XL999 in Non-Small Cell Lung Cancer (NSCLC) Patients
Apr25
Pharmos’ Cannabinor Passed Phase 2a Trial for Nociceptive Pain in Third Molar Dental Extraction Model
Phase III Clinical Trials of Amarin Corp.’s Miraxion in Huntington’s Disease, Did not Meet Target Endpoints
USFDA NDA for Xcytrin® Injection for Lung Cancer Brain Metastases Treatment, Submitted by Pharmacyclics
Apr23
The USFDA, Podcasting and Drug Safety Information
Lovenox® is Superior over Unfractionated Heparin in Reducing Risk of Venous ThromboEmbolism in Acute Ischemic Stroke Patients
6th Annual European Drug Delivery Partnerships 2007
Apr22
Interesting Finds: Pharma-related Posts 7
Apr21
Addex Pharmaceuticals’ ADX10059 Passed Phase IIa Migraine Clinical Trial
Baxter’s Inhaled Insulin Passed Phase I Study
Apr20
Access Pharmaceuticals Signed Merger with Somanta Pharmaceuticals
Allos Therapeutics’ PDX (pralatrexate), Granted EMEA Orphan Drug Designation
Apr19
Vote to Allow Medicare to Negotiate Lower Drug Prices, Blocked by Senate Minority
Eisai Completed Morphotek Acquisition
New Actonel® Dose for Postmenopausal Osteoporosis, Approved by the USFDA
Where the Big Bucks in Pharma Goes: Part 5 Video
Interesting Finds: Pharma-related Blog Posts 6
Apr18
Bill Clinton on Pharmaceutical Companies
USFDA Orphan Drug Designation Granted to Sirion Therapeutics’ Anti-viral Therapy Ganciclovir
GPC Biotech’s NDA for Satraplatin, Under USFDA Priority Review Status
The Big Bucks in Pharma is Spent on Advertising
USFDA Granted Final Approval to Mylan’s Glipizide and Metformin Hydrochloride Tablets
New Dose of RISPERDAL® CONSTA® for Treatment of Schizophrenia, Approved by the USFDA
Lupin’s Novel Formulation of Suprax® Suspension, Approved by the USFDA
GSK’s Altabax™ (Retapamulin Ointment), 1% - Approved by the USFDA
CTI’s XYOTAX™ Granted Fast Track Status in Women with Advanced Lung Cancer Who Are Performance Status 2 (PS2)
Apr17
Transgene and Roche Collaborates on Therapeutic Vaccines Against HPV-Mediated Diseases
GRIFULVIN V®/Griseofulvin Oral Suspension: Voluntarily Recalled by Ortho-McNeil Pharmaceutical, Inc.
USFDA New Drug Application (NDA) of Anesthetic Reversal Agent NV-101, Submitted by Novalar
Apr16
'Was Away, Now Back
Apr12
Schering-Plough’s PEGINTRON™ Approved in China for Treatment of Chronic Hepatitis B
Melior Entered Research Collboration with Pfizer
Second Indication of Cangene’s HepaGam B™, Approved by the USFDA
Apr11
USFDA Approved Abbott’s New Coated Niaspan®
AVEO and Schering-Plough, Under Worldwide License and Development Agreement for AV-299
Novagali Pharma’s Vekacia® Passed Pivotal Vernal Keratoconjunctivitis Phase III Trial
Apr10
CSL Biotherapies Submitted BLA to the USFDA for Introduction of Flu Vaccine into U.S. Market
Boston Scientific’s TAXUS® Express2™ Stent System, Approved in Japan
Wyeth Purchased Wyeth K.K. Japan
Apr 9
Eli Lilly Has Completed Acquisition of Hypnion
Apr 4
Of Christ’s Passion, Holiday Temptation and Interesting Pharma-related Finds
Abbott Submitted E.U. and U.S. Regulatory Application for HUMIRA® (Adalimumab) as Psoriasis Treatment
Apr 3
CSL Behring’s Rhophylac®, Approved by the USFDA for the Treatment of Immune Thrombocytopenic Purpura (ITP)
Accelerated Dosing Schedule of GSK’s Twinrix®, Approved by the USFDA
Apr 2
FDA Advisory Committee Recommends Approval of Dendreon’s PROVENGE® for Advanced Prostate Cancer Treatment
U.S. Marketing Rights to Novel Menopause Drug EvaMist™, Acquired by KV Pharmaceutical Company
GSK Submitted EU Regulatory Approval for Meningococcal Conjugate Vaccine, Globorix™
Novartis Heeds FDA Request to Suspend US Marketing and Sales of Zelnorm®
Apr 1
Curagen is Selling 454 Life Sciences to Roche
GSK Submitted BLA to USFDA for Candidate Cervical Cancer Vaccine, CERVARIX®
Baxter’s Adjuvant-free H5N1 Flu Vaccine Passed Final Phase I/II Clinical Trial, Continuing to Phase III

« March 2007 | Main | May 2007 »

Advertise

Watch the Digital Health Revolution


sponsored ads



Incredible Hall of Acclaim.

subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

WebMetricsGuru

TheInsurancePolicy

MarketingBlurb